Your browser doesn't support javascript.
loading
Temporal trends in prevalence of liver cancer and etiology-specific liver cancer from 1990 to 2019.
Yang, Chunhua; Jia, Jia; Yu, Yue; Lu, Hao; Zhang, Liwei.
Affiliation
  • Yang C; Department of Blood Transfusion, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, PR China. Electronic address: chyang@xah.xmu.edu.cn.
  • Jia J; Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, Xiamen, PR China.
  • Yu Y; Department of Thoracic and Comprehensive Cancers Radiotherapy, the First Affiliated Hospital of University, School of Medicine, Xiamen University, Xiamen, 361005, PR China.
  • Lu H; School of Medicine, Xiamen University, Xiamen, 361005, PR China.
  • Zhang L; Department of Anesthesiology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, PR China. Electronic address: lwzhang@xah.xmu.edu.cn.
Clin Res Hepatol Gastroenterol ; 48(8): 102451, 2024 Oct.
Article in En | MEDLINE | ID: mdl-39174005
ABSTRACT

BACKGROUND:

Liver cancer (LC) remains a major cause of cancer death worldwide. Grasping prevalence trends is key to informing strategies for control and prevention. We analyzed the global, regional and national trends in LC prevalence and its major causes from 1990 to 2019.

METHODS:

We obtained LC age-standardized prevalence rate (ASPR) estimates from the Global Burden of Disease study 2019 and assessed trends using Joinpoint regression. LC cases were categorized into those due to hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol use, nonalcoholic steatohepatitis (NASH) and other causes.

RESULTS:

While the ASPR of LC has shown a global decrease, there are specific regions where an increase in ASPR has been observed, with the highest rates in America. HBV remained the leading cause of LC (41.45 %) but significant increases occurred for HCV, alcohol use and NASH. Prevalence correlated with socioeconomic development. High-income countries had higher LC rates from HCV and alcohol but lower HBV-related LC. In high-income nations, LC prevalence climbs; the converse holds in middle- and low-income countries.

CONCLUSIONS:

Despite a global ASPR decrease, LC due to HCV, NASH, and alcohol is rising. Prevention strategies must prioritize HBV vaccination, HCV treatment, and alcohol regulation. IMPACT The study informs targeted LC control policies and emphasizes the importance of continued monitoring and regional cooperation to combat LC.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Res Hepatol Gastroenterol Year: 2024 Document type: Article Country of publication: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Res Hepatol Gastroenterol Year: 2024 Document type: Article Country of publication: France